adenosine has been researched along with Liver Neoplasms in 143 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (16.78) | 18.7374 |
| 1990's | 9 (6.29) | 18.2507 |
| 2000's | 11 (7.69) | 29.6817 |
| 2010's | 34 (23.78) | 24.3611 |
| 2020's | 65 (45.45) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, M; Fang, L; Guo, RP; Li, SH; Mei, J; Wei, W; Zhao, RC; Zou, JW | 1 |
| Chen, A; Li, Y; Shao, J; Shen, M; Wang, Y; Yin, G; Zhang, F; Zhang, Z; Zheng, S | 1 |
| Lou, J; Ni, J; Shao, Y; Shi, C; Wei, S; Zhao, H; Zhou, Q | 1 |
| Lu, WJ; Yu, S; Zhu, HX; Zhu, WP | 1 |
| Chen, J; Liu, T; Tang, H; Zhang, Q | 1 |
| Cui, Z; Deng, L; Huang, N; Li, G; Ma, J; Pan, Q; Sun, F; Wu, Q | 1 |
| Cai, JB; Fan, J; Gao, C; Guo, XJ; Huang, XY; Ke, AW; Lu, JC; Shi, GM; Shi, YH; Sun, QM; Wang, SW; Zeng, HY; Zhang, PF; Zheng, YM; Zhou, J | 1 |
| Cai, X; Chen, Y; Ge, J; Ling, Z; Lv, Z; Man, D; Wu, J; Xie, H; Xu, Y; Yu, C; Zhang, D; Zhang, Y; Zheng, S; Zhou, L | 1 |
| Dzubak, P; Hajduch, M; Kotulova, J; Kourilova, P; Kubickova, A; Lonova, K; Vrbkova, J | 1 |
| Chen, CW; Chen, J; Chen, Z; Deng, X; Dong, L; Gao, L; Gao, M; Han, L; He, C; He, PC; Horne, D; Huang, W; Li, C; Li, W; Li, Y; Liu, W; Nam, Y; Prince, E; Qin, H; Qin, X; Qing, Y; Rosen, ST; Shen, C; Su, R; Sun, M; Tan, B; Wei, J; Wu, X; Xue, J; Xue, M; Zhao, Z; Zhou, K | 1 |
| He, C; Tong, C; Wang, W | 1 |
| Cao, Y; Chao, G; Liu, S; Pan, H; Wang, P; Wu, S | 1 |
| Cai, MY; Chen, RX; Chen, W; Deng, MH; Duan, JL; Han, K; Liang, H; Mei, J; Nie, RC; Teng, K; Wang, FW; Xiang, ZC; Xie, D; Xie, JJ; Yin, YX; Zhang, ML; Zhang, N | 1 |
| Mo, YY; Peng, WX | 1 |
| Ke, W; Lu, Z; Zhang, L; Zhao, X | 1 |
| Chen, S; Ding, Z; Ke, TY; Long, N; Shao, W; Shen, YX; Sheng, MF; Wang, W; Wang, XY; Wang, YY; Xu, RY; Xu, YZ; Zhao, Q | 1 |
| Bian, Z; Cui, Z; Gu, S; He, J; Huang, N; Liu, L; Man, Q; Sun, F; Sun, G; Xu, C; Xu, W; Zhang, Y; Zhuang, C | 1 |
| Auld, FM; Leng, R; Sergi, CM; Shen, F | 1 |
| Cao, Y; Geng, C; He, G; Liu, S; Pan, H; Wu, S | 1 |
| Bai, M; Feng, Z; Fu, Y; Hua, Y; Ke, S; Li, X; Li, Z; Lu, S; Ma, Y; Pan, S; Qian, B; Wang, C; Xu, Y; Yin, B; Yu, H; Zhou, M; Zhou, Y | 1 |
| Chen, X; He, J; Jin, H; Liu, G; Mao, Y; Qin, S; Qin, Y; Xiao, J; Zhao, L | 1 |
| Gu, J; Kong, Y; Wang, Y; Wei, W; Wu, Y; Yang, Q; Zhou, D; Zhou, W | 1 |
| Chen, B; Guo, S; Han, H; Kuang, M; Lin, S; Ma, J; Peng, H; Peng, S; Wang, L; Wei, W; Yang, C | 1 |
| Chen, F; Hu, J; Li, H; Liu, X; Mao, M; Peng, X; Song, J; Yang, L | 1 |
| Fan, F; Qian Cai, Q; Sheng Fu, L; Wei Dong, Y; Yang, Y; Zhong Wu, X | 1 |
| Feng, XM; Ji, XL; Liu, FY; Su, XL | 1 |
| Jiang, G; Li, H; Xie, Y; Zou, Y | 1 |
| Ha, JW; Jeon, S; Kang, K; Kim, HS; Kim, SY; Moon, K; Na, MJ; Nam, SW; Park, WS; Shin, E; Son, KH; Yang, HD | 1 |
| Fuji, T; Fujiwara, T; Hata, N; Kishimoto, H; Kondo, Y; Michiue, H; Mori, Y; Nakamura, K; Shigeyasu, K; Takahashi, T; Takeda, S; Tazawa, H; Teraishi, F; Umeda, H; Umeda, Y; Yamamoto, H; Yano, S; Yasui, K; Yoshida, K; Yoshida, R | 1 |
| Chen, H; Cheng, J; Du, J; Fu, J; He, T; Zhang, L; Zhang, W | 1 |
| Cheng, ZJ; Huang, SY; Kawaguchi, T; Li, HF; Liang, B; Ni, JS; Samant, H; Tao, YP; Wang, ZG; Wu, J; Xiang, DM; Yang, L; Yang, Y; Yuan, SX; Zheng, H; Zhou, WP | 1 |
| Bao, MH; Chan, CY; Cheu, JW; Chiu, DK; Chui, NN; Deng, H; Goh, CC; Kwan, KK; Law, CT; Li, Q; Liu, CX; Ng, IO; Ooi, ZY; Shen, W; Sit, GF; Tse, AP; Wong, BP; Wong, CC; Yang, C; Yuen, VW; Zhang, MS | 1 |
| Feng, K; Mao, X; Niu, K; Shi, Y; Wang, Y; Zhang, W; Zhang, Y | 1 |
| Henault, D; Kadoury, S; Messaoudi, N; Montagnon, E; Rebolledo, R; Saber, R; Soucy, G; Stagg, J; Tang, A; Turcotte, S | 1 |
| Liu, Y; Si, Z; Wang, X; Yu, L; Zhou, M | 1 |
| Chagoya De Sánchez, V; Chávez, E; Domínguez-López, M; Lozano-Rosas, MG; Martínez-Pérez, L; Velasco-Loyden, G | 1 |
| Feng, M; He, C; Hou, J; Hu, B; Huang, X; Liu, J; Lu, Z; Shen, B; Smyth, MJ; Sun, B; Wang, J; Xia, Q; Zhang, H; Zhao, Z; Zhou, J | 1 |
| Chen, X; Hao, X; Huang, J; Lan, T; Li, H; Li, J; Liao, H; Liao, M; Liu, H; Wu, H; Xie, K; Xu, L; Yan, X; Yuan, K; Zeng, Y; Zhang, D | 1 |
| Cai, J; Cao, M; Chen, Z; Gao, W; Wang, J; Wang, X; Wu, J; Zhang, Y; Zuo, X | 1 |
| Fang, J; Li, F; Li, Z; Peng, Y; Zhou, J | 1 |
| Cui, X; Fan, Y; Li, J; Ren, Z; Sun, R; Wang, Z; Zhang, D; Zhao, W; Zhu, J | 1 |
| Bo, X; Jiang, H; Liu, Z; Qin, S; Qu, N; Tan, C; Wen, G; Zhang, X | 1 |
| Chen, M; Wong, CM | 1 |
| Dai, C; Ding, H; Jia, C; Su, Y; Zhang, X | 1 |
| Bo, H; Cao, K; Chen, X; Gong, L; Guo, F; He, D; Li, R; Li, X; Liu, J; Liu, X; Wang, F; Wang, Q; Wang, X; Xiao, W; Xing, X; Xiong, W; Xu, C; Zeng, Q; Zhou, J; Zhou, M; Zhou, Y; Zhu, Y | 1 |
| He, X; Hou, B; Huang, K; Huang, S; Ji, F; Ma, Z; Ruan, S; Zhang, C; Zhou, Z; Zhuang, H | 1 |
| Bu, X; Chen, D; Chen, L; Chen, X; Cheng, C; He, W; Liang, H; Lin, Z; Niu, Y; Sun, L; Wan, A; Wan, G; Zhan, S; Zhang, X | 1 |
| Chen, P; Dai, X; Tao, L; Wu, X; Zhang, X | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Chang, Z; Li, Z; Liu, Y; Lu, X; Luo, C; Qiao, K; Sun, T; Xu, Z; Yang, C; Zhang, C; Zhang, H | 1 |
| He, Y; Shi, Q; Xue, C; Yu, Z; Yuan, X | 1 |
| Chu, Y; Huang, Z; Li, Z; Wang, J; Wang, Y; Xu, J; Yu, X; Zheng, L | 1 |
| Chen, X; Gao, T; He, B; Li, C; Liu, X; Pan, B; Pan, Y; Qin, J; Sun, H; Wang, S; Xu, M; Xu, T; Xu, X; Zeng, K | 1 |
| Cai, X; Cen, D; Gorshkov, K; Ji, L; Jiang, S; Liang, X; Lin, Z; Mao, Q; Tang, M; Wan, Z; Xia, S; Xu, J; Zheng, J | 1 |
| Hayashi, M; Inokawa, Y; Kanda, M; Kandimalla, R; Kodera, Y; Koike, M; Nakagawa, N; Nakayama, G; Sonohara, F; Sunagawa, Y; Takami, H; Tanaka, C; Tanaka, K; Yamada, S | 1 |
| Han, F; Li, Q; Wang, T; Wang, Z; Yang, N; Zhou, J; Zhu, R | 1 |
| Huang, C; Li, J; Pan, XY | 1 |
| Arumugam, T; Chuturgoon, AA; Ghazi, T | 1 |
| Hu, Y; Jiang, R; Li, Q; Ni, Y; Pu, L; Qiu, J; Tang, J; Wang, X; Xu, J; Yang, H; Zhang, L | 1 |
| Liu, J; Wang, D; Wang, L; Yang, M; Zeng, J; Zhang, N; Zhou, J; Zhou, L | 1 |
| Akalın, H; Baskol, G; Baskol, M; Kilic, E; Özel, M | 1 |
| Yu, ZL; Zhu, ZM | 1 |
| Gao, W; Huang, H; Jin, L; Lin, J; Qu, S; Zeng, Z | 1 |
| Jiang, H; Lv, W; Ning, G; Wang, Y | 1 |
| Cai, J; Xu, J; Zhou, M | 1 |
| Chen, X; Jiang, J; Li, D; Wang, A; Yang, L | 1 |
| Chen, X; Mao, Y; Qin, S; Qin, Y; Xiao, J; Zhao, L | 1 |
| Du, Z; Gao, Y; Luo, Y; Wang, N; Wang, P; Wu, G; Yang, B; Zhang, Y; Zhu, Z | 1 |
| Belužić, L; Belužić, R; Brkljačić, L; Espadas, G; Grbeša, I; Jerić, I; Kong, HK; Kopjar, N; Lepur, A; Park, JH; Rokić, F; Sabidó, E; Vugrek, O | 1 |
| Battaglin, F; Berger, MD; Cao, S; Cremolini, C; Falcone, A; Heinemann, V; Lenz, HJ; Lo, JH; Loupakis, F; Millstein, J; Naseem, M; Puccini, A; Soni, S; Stintzing, S; Tokunaga, R; Zhang, W | 1 |
| Bian, Z; Chen, Y; Du, L; Liu, Y; Pan, Q; Qian, Z; Sun, F; Wang, J; Wu, Q; Xu, W; Xu, Y; Yu, Y; Zhang, X; Zhang, Y; Zheng, W; Zhu, G | 1 |
| Bley, N; Chen, J; Dahl, A; Fuchs, T; Glaß, M; Haase, J; Huang, H; Hüttelmaier, S; Lederer, M; Müller, S; Posern, G; Singh, AK | 1 |
| Borodovsky, A; Fretland, AJ; Gangl, E; Goodwin, KJ; Jones, N; Pop-Damkov, P; Sarkar, U; Woessner, R | 1 |
| Kang, T; Li, X; Liao, D; Ma, H; Zeng, C; Zhang, M; Zhang, R; Zhong, L | 1 |
| Cai, J; Chen, H; Chen, K; Dai, Q; Fan, J; He, C; Klaholz, BP; Lan, F; Lu, Z; Lv, R; Ma, H; Natchiar, SK; Pan, T; Shi, Y; Shi, YG; Wang, X | 1 |
| Feng, JL; Li, GP; Liu, LX; Pu, ZJ; Wu, LF; Zhou, XT; Zhu, HC | 1 |
| Hamada, M; Zhang, Y | 1 |
| An, P; Chen, F; Chen, Z; Du, J; Jiang, G; Li, J; Liu, H; Lu, L; Luo, N; Shan, H; Tian, L; Wang, H; Wu, Y; Yang, X | 1 |
| Chai, G; Chen, F; Du, J; He, C; Li, J; Lin, S; Lin, X; Liu, J; Luo, G; Tauler, J; Wang, H; Wu, Y | 1 |
| Guo, Y; Li, G; Liu, L; Pu, Z; Tan, H; Wu, L; Xiang, M; Zhan, H; Zhou, X | 1 |
| Chung, AY; Hui, KM; Huynh, H; Lam, PY; Lim, KH; Ooi, LL; Sia, KC | 1 |
| Chen, YM; Chiang, EP; Lin, WL; Lin, YJ; Tang, FY; Wang, YC | 1 |
| Deng, W; Feng, JL; Guo, YT; Huang, GY; Pu, ZJ; Wu, LF; Xiang, MQ; Ye, YQ; Zhang, QH | 1 |
| Chan, TH; Chen, L; Qi, L; Tenen, DG | 1 |
| Chen, P; Liu, F; Liu, H; Liu, J; Ma, Y; Song, C; Song, J; Yang, D; Yu, S; Zhang, J; Zhang, Q | 1 |
| Bezuhly, M; Gebremeskel, S; Johnston, B; LeVatte, T; Liwski, RS | 1 |
| Chen, RP; Deng, W; Guo, YT; Li, R; Liu, LX; Pu, ZJ; Wang, GF; Wu, LF; Xiang, MQ; Zhou, XT | 1 |
| Liu, F; Ma, JZ; Sun, SH; Wang, F; Wang, TT; Xu, QG; Yang, F; Yuan, JH; Zhou, CC; Zhou, WP | 1 |
| Feng, G; Gao, S; Li, J; Li, Y; Liu, Y; Wang, Y; Yang, Z; Ye, L; Zhang, S; Zhang, X | 1 |
| Berry, D; Bikchandani, J; Dennison, A; Illouz, S; Lloyd, D; Nakamura, T; Robertson, G; Thava, B; Wada, H; Webb, M | 1 |
| Bar-Yehuda, S; Barer, F; Castel, D; Cohen, S; Del Valle, L; Fishman, P; Madi, L; Ochaion, A; Perez-Liz, G; Stemmer, SM; Zabutti, A | 1 |
| Gwak, MS; Kim, GS; Kim, HK; Kim, JK; Ko, JS; Lee, SK; Shin, BS; Yang, M | 1 |
| Ishizawa, Y; Lim, CR; Nakano, T; Nishizaki, T; Yaguchi, T; Yang, D | 1 |
| Nakano, T; Nishizaki, T; Yaguchi, T; Yang, D | 1 |
| Feng, JL; Li, GP; Pu, ZJ; Su, JD; Wei, BL; Wu, LF; Ye, YQ | 1 |
| Feng, JL; Huang, GY; Li, GP; Li, HB; Pu, ZJ; Wei, BL; Wu, LF; Ye, YQ | 1 |
| Bar-Yehuda, S; Barer, F; Cohen, S; Fishman, P; Jacobson, KA; Ochaion, A; Patoka, R; Rath-Wolfson, L; Stemmer, SM; Zozulya, G | 1 |
| Chiba, T; Imazeki, F; Iwama, A; Kanai, F; Konuma, T; Miyagi, S; Negishi, M; Saraya, A; Suzuki, E; Tada, M; Tanaka, S; Yokosuka, O | 1 |
| Chen, F; Chen, Z; Wu, S; Xue, J; Zhou, L | 1 |
| Cetin Atalay, R; Guven, EB; Onder, T; Tuncbilek, M | 1 |
| Exner, A; Haaga, JR; Wilkins, LR; Wu, H | 1 |
| Bar-Yehuda, S; Benjaminov, O; Ciuraru, NB; Cohen, S; Farbstein, M; Fishman, P; Fishman, S; Harpaz, Z; Kerns, WD; Medalia, G; Patoka, R; Silverman, MH; Singer, B; Stemmer, SM | 1 |
| LEMARCHAL, P; MUNSCH, N | 1 |
| Arich, A; Bar-Yehuda, S; Dreznick, Z; Fishman, P; Madi, L; Ohana, G; Rath-Wolfson, L; Silberman, D; Slosman, G | 1 |
| Casado, FJ; Casadó, V; Duflot, S; Fernández-Veledo, S; Franco, R; Lluís, C; Norman, RI; Pastor-Anglada, M; Riera, B | 1 |
| Quan, F; Quan, W; Ramirez, M; Taylor, C; Vinogradov, M; Walker, P | 1 |
| Feng, JL; Li, GP; Pu, ZJ; Wu, LF | 1 |
| Nishizaki, T; Yaguchi, T; Yamamoto, H; Yang, D | 1 |
| Hermes, M; Kloor, D; Osswald, H | 1 |
| Liu, S; Liu, Y; Sun, M; Zhang, J; Zheng, D | 1 |
| Brown, JD; Poirier, LA; Wilson, MJ | 1 |
| Aggarwal, S; Agrawal, K; Brookins, J; Fisher, JW; Nakashima, J; Ohigashi, T | 1 |
| Delrivière, L; Hannoun, L | 1 |
| Brookins, J; Fisher, JW; Ohigashi, T | 1 |
| Agrawal, KC; Beckman, BS; Brookins, JW; Fisher, JW; Nakashima, J; Ohigashi, T | 1 |
| Fisher, JW; Nakashima, J; Tazaki, H | 1 |
| Agarwal, KC; Tzanakakis, GN; Vezeridis, MP | 1 |
| Allen, PT; Poirier, LA | 1 |
| Brookins, J; Fisher, JW | 1 |
| Bolt, HM; Kunz, W; Laib, RJ; Stöckle, G | 1 |
| Behrens, M; Plagemann, PG | 1 |
| Rapaport, E; Zamecnik, PC | 1 |
| Marz, R; Plagemann, PG; Wohlhueter, RM | 1 |
| Busch, H; Choi, YC; Crain, PF; McCloskey, JA | 1 |
| Jackson, RC; Morris, HP; Weber, G | 1 |
| Anderson, LM; Budinger, JM; Giner-Sorolla, A; Greenbaum, JH; Last-Barney, K | 1 |
| Altman, NH; Brada, Z; Bulba, S | 1 |
| Kojima, S; Sakai, K; Yamane, Y | 1 |
| Beckman, B; Brookins, J; Fisher, JW; Nakashima, J | 1 |
| Alfani, D; Berloco, P; Bruzzone, P; Caricato, M; Casciaro, G; Cortesini, R; Iappelli, M; Marciani, A; Rossi, M; Urbano, D | 1 |
| Fritz, JE; Kenney, FT; Lee, KL; Stiles, CD | 1 |
| Plagemann, PG | 3 |
| Plagemann, PG; Schröder, J | 1 |
| Kerr, SJ | 1 |
| Miller, RL; Plagemann, PG | 1 |
| Erbe, J; Plagemann, PG | 1 |
| Hurlbert, RB; Orengo, A; Schaffer, M | 1 |
| Billings, PB; Martin, TE; Quinlan, TJ | 1 |
| Desrosiers, R; Friderici, K; Rottman, F | 1 |
| Bethune, VG; Fleisher, M; Schwartz, MK | 1 |
| Busse, HJ; Eismann, R; Nilius, R; Otto, L; Peters, JE; Zipprich, B | 1 |
7 review(s) available for adenosine and Liver Neoplasms
| Article | Year |
|---|---|
Roles of M
Topics: Adenosine; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Methylation; Methyltransferases | 2022 |
The Role of N
Topics: Adenosine; Hepatoblastoma; Humans; Liver Neoplasms; Liver Transplantation; Neoplasm Recurrence, Local | 2022 |
The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis.
Topics: Adenosine; Animals; Biomarkers, Tumor; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; RNA Processing, Post-Transcriptional; RNA, Neoplasm | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
The emerging roles of m
Topics: Adenosine; Animals; Carcinogenesis; Carcinoma, Hepatocellular; Chromosomal Instability; Hepatitis, Viral, Human; Humans; Lipid Metabolism; Liver Neoplasms; Molecular Targeted Therapy; Neovascularization, Pathologic | 2021 |
The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma.
Topics: Adenosine; Carcinoma, Hepatocellular; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Prognosis; RNA, Circular | 2021 |
RNA editome imbalance in hepatocellular carcinoma.
Topics: Adenosine; Animals; Carcinoma, Hepatocellular; Humans; Inosine; Liver Neoplasms; RNA; RNA Editing | 2014 |
3 trial(s) available for adenosine and Liver Neoplasms
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
CF102 for the treatment of hepatocellular carcinoma: a phase I/II, open-label, dose-escalation study.
Topics: Adenosine; Adult; Aged; Apoptosis; Carcinoma, Hepatocellular; Child; Female; Humans; Leukocytes, Mononuclear; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Purinergic P1 Receptor Agonists; Receptor, Adenosine A3; Sorafenib; Wnt Signaling Pathway | 2013 |
Administration of high-dose continuous infusion interleukin-2 to patients age 70 or over.
Topics: Adenosine; Aged; Aged, 80 and over; Aging; Capillary Leak Syndrome; Famotidine; Hemodynamics; Humans; Immunotherapy; Infusions, Intravenous; Interleukin-2; Kidney Neoplasms; Killer Cells, Lymphokine-Activated; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Melanoma; Time Factors; Treatment Outcome | 2005 |
134 other study(ies) available for adenosine and Liver Neoplasms
| Article | Year |
|---|---|
Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma.
Topics: Adenosine; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cluster Analysis; Computational Biology; Databases, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Methylation; Prognosis; Protein Interaction Mapping; Protein Interaction Maps; RNA; ROC Curve; Transcriptome | 2021 |
N
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Autophagy; Carcinoma, Hepatocellular; Ferroptosis; Hepatic Stellate Cells; Humans; Liver Neoplasms; Mice; Retrospective Studies; Signal Transduction | 2021 |
RNA N6-Methyladenosine Patterns in Hepatocellular Carcinoma Reveal a Distinct Immune Infiltration Landscape and Clinical Significance.
Topics: Adenosine; Biomarkers, Tumor; Carcinoma, Hepatocellular; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Prognosis; RNA; Tumor Microenvironment | 2021 |
Comprehensive analysis of N
Topics: Adenosine; Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Prognosis; Proportional Hazards Models; RNA, Long Noncoding; Tumor Microenvironment | 2021 |
m
Topics: Adenosine; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Apoptosis; Autophagy; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Liver Neoplasms; Phosphorylation; RNA Splicing Factors; Signal Transduction; Up-Regulation | 2021 |
Amplification of spatially isolated adenosine pathway by tumor-macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma.
Topics: Adenosine; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Immune Checkpoint Inhibitors; Liver Neoplasms; Signal Transduction | 2021 |
Activation of YAP1 by N6-Methyladenosine-Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma.
Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Methylation; Middle Aged; Prognosis; RNA-Binding Proteins; RNA, Circular; YAP-Signaling Proteins | 2022 |
2‑Cl‑IB‑MECA regulates the proliferative and drug resistance pathways, and facilitates chemosensitivity in pancreatic and liver cancer cell lines.
Topics: Adenosine; Cell Line; Cell Line, Tumor; Cell Proliferation; Drug Resistance; Hedgehog Proteins; Humans; Liver Neoplasms; Pancreatic Neoplasms; Zinc Finger Protein GLI1 | 2022 |
METTL16 exerts an m
Topics: Adenosine; Animals; Carcinogenesis; Carcinoma, Hepatocellular; Cytosol; Eukaryotic Initiation Factor-3; Gene Expression Regulation, Neoplastic; HEK293 Cells; Hep G2 Cells; Humans; Liver Neoplasms; Methyltransferases; Mice, Inbred NOD; Mice, SCID; Protein Biosynthesis; RNA Processing, Post-Transcriptional; RNA, Messenger; RNA, Ribosomal; Signal Transduction; Tumor Burden | 2022 |
m1A methylation modification patterns and metabolic characteristics in hepatocellular carcinoma.
Topics: Adenosine; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Methylation; Prognosis; RNA Processing, Post-Transcriptional | 2022 |
Downregulation of ZC3H13 by miR-362-3p/miR-425-5p is associated with a poor prognosis and adverse outcomes in hepatocellular carcinoma.
Topics: Adenosine; Carcinoma, Hepatocellular; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; MicroRNAs; Nuclear Proteins; Prognosis; RNA-Binding Proteins; Tumor Microenvironment | 2022 |
A novel peptide encoded by N6-methyladenosine modified circMAP3K4 prevents apoptosis in hepatocellular carcinoma.
Topics: Adenosine; Apoptosis; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Peptides | 2022 |
Connecting N6-methyladenosine modification to ferroptosis resistance in hepatoblastoma.
Topics: Adenosine; Ferroptosis; Hepatoblastoma; Humans; Liver Neoplasms | 2022 |
Resina Draconis extract exerts anti-HCC effects through METTL3-m6A-Survivin axis.
Topics: Adenosine; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Liver Neoplasms; Methyltransferases; Mice; Mice, Nude; Plant Extracts; RNA, Messenger; Survivin | 2022 |
An Alternatively Spliced Variant of METTL3 Mediates Tumor Suppression in Hepatocellular Carcinoma.
Topics: Adenosine; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Methyltransferases; RNA, Messenger | 2022 |
The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
Topics: Adenosine; Amino Acid Transport System y+; Animals; Ferroptosis; Hepatoblastoma; Humans; Immediate-Early Proteins; Liver Neoplasms; Methyltransferases; RNA, Messenger; Tumor Suppressor Proteins | 2022 |
Identification and validation of the N6-methyladenosine RNA methylation regulator ZC3H13 as a novel prognostic marker and potential target for hepatocellular carcinoma.
Topics: Adenosine; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Methylation; Nuclear Proteins; Prognosis; RNA; RNA-Binding Proteins | 2022 |
Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma.
Topics: Adenosine; Apolipoproteins; Biomarkers; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male | 2022 |
The comprehensive expression and functional analysis of m6A modification "readers" in hepatocellular carcinoma.
Topics: Adenosine; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Prognosis; Repressor Proteins; RNA, Messenger | 2022 |
m6A regulator-mediated methylation modification highlights immune infiltration patterns for predicting risk in hepatocellular carcinoma.
Topics: Adenosine; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Methylation; RNA; Tumor Microenvironment | 2023 |
N
Topics: Adenosine; Animals; Carcinogenesis; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Fatty Acids; Lipid Metabolism; Liver Neoplasms; Mice; RNA, Ribosomal, 18S | 2022 |
METTL3 promotes m6A hypermethylation of RBM14 via YTHDF1 leading to the progression of hepatocellular carcinoma.
Topics: Adenosine; Carcinoma, Hepatocellular; DNA Methylation; Humans; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Methyltransferases; RNA-Binding Proteins; Tumor Microenvironment | 2022 |
Reduced N6-Methyladenosine Mediated by METTL3 Acetylation Promotes MTF1 Expression and Hepatocellular Carcinoma Cell Growth.
Topics: Acetylation; Adenosine; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Methyltransferases; RNA, Messenger; Sulfoglycosphingolipids | 2022 |
[Cluster classification and clinical prognostic modeling based on m6A RNA methylation regulators in liver cancer].
Topics: Adenosine; Humans; Liver Neoplasms; Methylation; Prognosis; RNA | 2022 |
m6A-Related Genes Contribute to Poor Prognosis of Hepatocellular Carcinoma.
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Methyltransferases; Prognosis | 2022 |
ADAR1-dependent miR-3144-3p editing simultaneously induces MSI2 expression and suppresses SLC38A4 expression in liver cancer.
Topics: Adenosine; Adenosine Deaminase; Animals; Carcinogenesis; Cell Line, Tumor; Liver Neoplasms; Mice; MicroRNAs | 2023 |
ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metastasectomy for colorectal cancer.
Topics: Adenosine; Adenosine Deaminase; Biomarkers; Colorectal Neoplasms; Humans; Liver Neoplasms; Metastasectomy; Risk Assessment; RNA; RNA-Binding Proteins | 2023 |
Effect of DPP4/CD26 expression on SARS‑CoV‑2 susceptibility, immune response, adenosine (derivatives m
Topics: Adenocarcinoma; Adenosine; Carcinoma, Hepatocellular; COVID-19; Dipeptidyl Peptidase 4; Female; Humans; Immunity; Liver Neoplasms; Male; Melanoma; Melanoma, Cutaneous Malignant; Pancreatic Neoplasms; Pandemics; Prospective Studies; SARS-CoV-2; Skin Neoplasms | 2023 |
N
Topics: Adenosine; Bone Neoplasms; Carcinoma, Hepatocellular; Carrier Proteins; Humans; Liver Neoplasms; Methyltransferases; Tumor Microenvironment | 2023 |
Hypoxia-inducible factor orchestrates adenosine metabolism to promote liver cancer development.
Topics: Adenosine; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Hypoxia; Liver Neoplasms; Mice; Mice, Knockout; Tumor Microenvironment | 2023 |
N6-methyladenosine with immune infiltration and PD-L1 in hepatocellular carcinoma: novel perspective to personalized diagnosis and treatment.
Topics: Adenosine; B7-H1 Antigen; Carcinoma, Hepatocellular; Humans; Immunotherapy; Liver Neoplasms; Tumor Microenvironment | 2023 |
Radiomics using computed tomography to predict CD73 expression and prognosis of colorectal cancer liver metastases.
Topics: 5'-Nucleotidase; Adenosine; Colorectal Neoplasms; Humans; Liver Neoplasms; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
m6A modified BACE1-AS contributes to liver metastasis and stemness-like properties in colorectal cancer through TUFT1 dependent activation of Wnt signaling.
Topics: Adenosine; Amyloid Precursor Protein Secretases; Aspartic Acid Endopeptidases; Cell Line, Tumor; Colorectal Neoplasms; Dental Enamel Proteins; Humans; Liver Neoplasms; RNA-Binding Proteins; RNA, Antisense; Wnt Signaling Pathway | 2023 |
Diminished S-adenosylmethionine biosynthesis and its metabolism in a model of hepatocellular carcinoma is recuperated by an adenosine derivative.
Topics: Adenosine; Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Humans; Liver Neoplasms; Male; Methionine Adenosyltransferase; Rats; Rats, Wistar; RNA-Binding Proteins; S-Adenosylmethionine; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2020 |
YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma.
Topics: Adenosine; Animals; Carcinoma, Hepatocellular; Epigenesis, Genetic; Humans; Inflammation; Liver Neoplasms; Methylation; Mice; Models, Biological; Neovascularization, Pathologic; RNA-Binding Proteins; RNA, Messenger; Transcriptome | 2019 |
KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
Topics: Adenosine; Animals; Cell Line, Tumor; Disease Models, Animal; Disease Progression; GATA3 Transcription Factor; Humans; Liver Neoplasms; Methylation; Mice; Models, Biological; Neoplasm Metastasis; Prognosis; RNA Processing, Post-Transcriptional; RNA-Binding Proteins; RNA, Antisense; RNA, Long Noncoding; Xenograft Model Antitumor Assays | 2019 |
M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma.
Topics: Adenosine; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease Progression; Gene Expression Regulation, Neoplastic; Genetic Therapy; Humans; Lipogenesis; Liver Neoplasms; Mice, Inbred BALB C; Mice, SCID; RNA, Long Noncoding; Up-Regulation | 2020 |
Identification of three m6A-related mRNAs signature and risk score for the prognostication of hepatocellular carcinoma.
Topics: Adenosine; Biomarkers, Tumor; Carboxy-Lyases; Carcinoma, Hepatocellular; Cell Line, Tumor; Datasets as Topic; Disease Progression; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Methylation; Methyltransferases; Nomograms; Risk Factors; RNA, Messenger; ROC Curve; Suppressor of Cytokine Signaling Proteins; Transaminases | 2020 |
Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
Topics: Adenosine; Animals; Disease Progression; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Hepatoblastoma; Humans; Liver Neoplasms; Male; Methyltransferases; Mice, Inbred C57BL; Mice, Nude; MicroRNAs; Prognosis; Wnt Signaling Pathway | 2020 |
Multiple m
Topics: Adenosine; Biomarkers, Tumor; Carcinoma, Hepatocellular; Disease Progression; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Methyltransferases; Neoplasm Grading; Prognosis; RNA-Binding Proteins; Sequence Analysis, RNA | 2020 |
GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation.
Topics: Adenosine; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chromogranins; Disease Progression; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; GTP-Binding Protein alpha Subunits, Gs; Humans; Inflammation; Interleukin-6; Lipopolysaccharides; Liver Neoplasms; Methylation; Mice; Mice, Inbred BALB C; Mice, Nude; Mutation; RNA Interference; RNA, Long Noncoding; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2020 |
SIRT1 Regulates N
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Computational Biology; Down-Regulation; Gene Expression Regulation, Neoplastic; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Liver Neoplasms; Male; Mice; Molecular Chaperones; Mutagenesis; Nuclear Pore Complex Proteins; Proteolysis; RNA Processing, Post-Transcriptional; RNA, Messenger; Sirtuin 1; Sumoylation; Xenograft Model Antitumor Assays | 2020 |
YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
Topics: Adenosine; Animals; Carcinoma, Hepatocellular; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Male; Methylation; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Neoplastic Stem Cells; Octamer Transcription Factor-3; Prognosis; RNA-Binding Proteins; RNA, Messenger; Spheroids, Cellular; Transplantation, Heterologous; Tumor Cells, Cultured | 2020 |
RNA m
Topics: Adenosine; Animals; Autophagy; Carcinoma, Hepatocellular; Drug Resistance, Neoplasm; Forkhead Box Protein O3; HEK293 Cells; Hep G2 Cells; Human Umbilical Vein Endothelial Cells; Humans; Liver Neoplasms; Male; Methylation; Methyltransferases; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Proteins; RNA, Messenger; RNA, Neoplasm; Sorafenib | 2020 |
Prognostic Value of an m6A RNA Methylation Regulator-Based Signature in Patients with Hepatocellular Carcinoma.
Topics: Adenosine; Carcinoma, Hepatocellular; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Methylation; Prognosis; Reproducibility of Results; Risk Factors; RNA, Neoplasm | 2020 |
RNA m6A methylation promotes the formation of vasculogenic mimicry in hepatocellular carcinoma via Hippo pathway.
Topics: Adaptor Proteins, Signal Transducing; Adenosine; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease Progression; Gene Expression Regulation, Neoplastic; Gene Silencing; Hippo Signaling Pathway; Humans; Liver Neoplasms; Methylation; Methyltransferases; Mice, Inbred BALB C; Mice, Nude; Molecular Mimicry; Prognosis; Protein Biosynthesis; Protein Serine-Threonine Kinases; RNA; RNA, Messenger; Signal Transduction; Transcription Factors; Xenograft Model Antitumor Assays; YAP-Signaling Proteins | 2021 |
Gene signatures and prognostic values of m1A-related regulatory genes in hepatocellular carcinoma.
Topics: Adenosine; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cohort Studies; Computational Biology; Disease Progression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Genes, Regulator; Humans; Liver Neoplasms; Phosphatidylinositol 3-Kinases; Prognosis; Protein Interaction Maps; RNA, Long Noncoding; Signal Transduction | 2020 |
Tumor-derived adenosine promotes macrophage proliferation in human hepatocellular carcinoma.
Topics: Adenosine; Adolescent; Adult; Aged; Aged, 80 and over; Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Female; Follow-Up Studies; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Liver Neoplasms; Macrophage Activation; Male; Middle Aged; Monocytes; Phenotype; Prognosis; Tumor-Associated Macrophages; Young Adult | 2021 |
Analysis of METTL3 and METTL14 in hepatocellular carcinoma.
Topics: Adenosine; Carcinoma, Hepatocellular; Databases, Genetic; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Liver Neoplasms; Methylation; Methyltransferases; RNA Stability; RNA, Messenger; Signal Transduction; Transcriptome | 2020 |
N
Topics: Adenosine; Animals; Antineoplastic Agents; Apoptosis; beta Catenin; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; RNA, Circular; Sorafenib; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2020 |
Novel Prognostic Implications of Methylated RNA and Demethylases in Resected HCC and Background Liver Tissue.
Topics: Adenosine; Adult; Aged; Aged, 80 and over; AlkB Homolog 5, RNA Demethylase; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Carcinoma, Hepatocellular; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Liver; Liver Neoplasms; Male; Methylation; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; RNA; Survival Analysis | 2020 |
HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.
Topics: Adaptor Proteins, Signal Transducing; Adenosine; Adult; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Survival; Female; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; Male; Methyltransferases; Models, Biological; Neoplasm Invasiveness; RNA, Messenger; Up-Regulation | 2021 |
Fumonisin B
Topics: Adenosine; Carcinoma, Hepatocellular; Epigenesis, Genetic; Fumonisins; Hep G2 Cells; Humans; Kelch-Like ECH-Associated Protein 1; Liver Neoplasms; Methylation; NF-E2-Related Factor 2; Oxidative Stress; RNA; Signal Transduction | 2021 |
HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.
Topics: Adaptor Proteins, Vesicular Transport; Adenosine; Animals; Autophagy; Autophagy-Related Proteins; Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; Mice; RNA; RNA-Binding Proteins | 2021 |
N6-methyladenosine reader YTHDC2 and eraser FTO may determine hepatocellular carcinoma prognoses after transarterial chemoembolization.
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Asian People; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cohort Studies; Genotype; Humans; Liver Neoplasms; Polymorphism, Single Nucleotide; Prognosis; Proportional Hazards Models; RNA Helicases; Treatment Outcome | 2021 |
The Effect of
Topics: Adenosine; Apoptosis; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Proliferation; Enhancer of Zeste Homolog 2 Protein; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Tumor Cells, Cultured | 2021 |
Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma.
Topics: Adenosine; Carcinoma, Hepatocellular; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Lymphocytes, Tumor-Infiltrating; Multivariate Analysis; Prognosis; Reproducibility of Results; RNA, Long Noncoding; Survival Analysis; Tumor Microenvironment | 2021 |
A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.
Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Animals; Carcinogenesis; Carcinoma, Hepatocellular; Case-Control Studies; Feedback, Physiological; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Histones; Humans; Intracellular Signaling Peptides and Proteins; Liver; Liver Neoplasms; Male; Mice; Middle Aged; Prognosis; Promoter Regions, Genetic; RNA-Seq; Trans-Activators; Viral Regulatory and Accessory Proteins; Xenograft Model Antitumor Assays | 2021 |
Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment Response.
Topics: Adenosine; Biomarkers, Tumor; Carcinoma, Hepatocellular; Databases, Genetic; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immune Checkpoint Inhibitors; Liver Neoplasms; Male; Neoplasm Staging; Prognosis; Sorafenib; Treatment Outcome | 2021 |
N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma.
Topics: Adenosine; Biomarkers, Tumor; Carcinoma, Hepatocellular; Endothelial Cells; Gene Expression Regulation, Neoplastic; Humans; Immunotherapy; Liver Neoplasms; Methylation; Prognosis; RNA; Tumor Microenvironment | 2021 |
METTL3-mediated m6A methylation of ASPM drives hepatocellular carcinoma cells growth and metastasis.
Topics: Adenosine; Apoptosis; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Disease Progression; DNA Methylation; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Methyltransferases; Nerve Tissue Proteins; Prognosis; Survival Rate; Tumor Cells, Cultured | 2021 |
Metabolic perturbation of epigenome by inhibiting S-adenosylhomocysteine hydrolase elicits senescence through DNA damage response in hepatoma cells.
Topics: Adenosine; Ataxia Telangiectasia Mutated Proteins; Carcinoma, Hepatocellular; Cell Proliferation; Cellular Senescence; Chromatin; Cyclin-Dependent Kinase Inhibitor p21; DNA Damage; Epigenomics; Hep G2 Cells; Histones; Humans; Liver Neoplasms; Metabolic Networks and Pathways; Methylation; S-Adenosylhomocysteine; S-Adenosylmethionine; Tumor Suppressor Protein p53 | 2017 |
Knock-down of AHCY and depletion of adenosine induces DNA damage and cell cycle arrest.
Topics: Adenosine; Adenosylhomocysteinase; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Proliferation; DNA Damage; Humans; Liver Neoplasms; Mutation; Proteome; RNA, Small Interfering; Transcriptome; Tumor Cells, Cultured | 2018 |
Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based Chemotherapy.
Topics: 5'-Nucleotidase; Adenosine; Antineoplastic Combined Chemotherapy Protocols; Apyrase; Bevacizumab; Biomarkers, Tumor; Camptothecin; Cetuximab; Cohort Studies; Colorectal Neoplasms; Female; Fluorouracil; Follow-Up Studies; GPI-Linked Proteins; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Irinotecan; Leucovorin; Liver Neoplasms; Male; Middle Aged; Polymorphism, Single Nucleotide; Prognosis; Receptors, Purinergic P1; Survival Rate | 2019 |
circRNA_104075 stimulates YAP-dependent tumorigenesis through the regulation of HNF4a and may serve as a diagnostic marker in hepatocellular carcinoma.
Topics: Adaptor Proteins, Signal Transducing; Adenosine; Adult; Aged; Animals; Biomarkers, Tumor; Carcinogenesis; Carcinoma, Hepatocellular; Cell Survival; Female; Hep G2 Cells; Hepatocyte Nuclear Factor 4; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Middle Aged; Promoter Regions, Genetic; Protein Interaction Domains and Motifs; RNA, Circular; ROC Curve; Transcription Factors; YAP-Signaling Proteins | 2018 |
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner.
Topics: Adenosine; Animals; Cell Line, Tumor; Disease-Free Survival; Female; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Lung Neoplasms; Male; Mice; MicroRNAs; Ovarian Neoplasms; RNA-Binding Proteins; Serum Response Factor; Xenograft Model Antitumor Assays | 2019 |
Development of a quantification method for adenosine in tumors by LC-MS/MS with dansyl chloride derivatization.
Topics: Adenosine; Animals; Brain Neoplasms; Calibration; Chromatography, Liquid; Liver Neoplasms; Mice; Tandem Mass Spectrometry | 2019 |
YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma.
Topics: 3' Untranslated Regions; Adenosine; Animals; Binding Sites; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; RNA Stability; RNA-Binding Proteins; RNA, Messenger; Signal Transduction; Tumor Burden; Tumor Hypoxia; Tumor Suppressor Proteins | 2019 |
N
Topics: Adenosine; Animals; Cell Proliferation; Humans; Liver Neoplasms; Male; Methylation; Methyltransferases; Mice, Inbred BALB C; Protein Biosynthesis; RNA, Ribosomal, 28S; Xenograft Model Antitumor Assays | 2019 |
Inhibition of autophagy enhances adenosine‑induced apoptosis in human hepatoblastoma HepG2 cells.
Topics: Adenosine; AMP-Activated Protein Kinases; Apoptosis; Autophagy; Autophagy-Related Protein-1 Homolog; Cell Survival; Chromones; Dose-Response Relationship, Drug; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; G1 Phase Cell Cycle Checkpoints; Gene Knockdown Techniques; Hep G2 Cells; Hepatoblastoma; Humans; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Morpholines; RNA, Small Interfering; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2019 |
DeepM6ASeq: prediction and characterization of m6A-containing sequences using deep learning.
Topics: Adenosine; Alternative Splicing; Animals; Brain; Carcinoma, Hepatocellular; Computational Biology; Deep Learning; Embryonic Stem Cells; Humans; Liver Neoplasms; Methylation; Mice; RNA; Sequence Analysis, RNA; Zebrafish | 2018 |
m
Topics: Adenosine; Animals; Base Sequence; Cell Line, Tumor; Colorectal Neoplasms; Epithelial-Mesenchymal Transition; F-Box Proteins; Female; Gene Expression Regulation, Neoplastic; Heterogeneous-Nuclear Ribonucleoprotein Group A-B; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Mice; Mice, Nude; Neoplasm Staging; Nuclear Proteins; Nucleic Acid Conformation; RNA, Long Noncoding; Signal Transduction; Survival Analysis; Ubiquitin-Protein Ligases; Xenograft Model Antitumor Assays; Zinc Finger E-box-Binding Homeobox 1 | 2019 |
RNA m
Topics: Adenosine; Animals; Cell Line, Tumor; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Kaplan-Meier Estimate; Liver; Liver Neoplasms; Methylation; Methyltransferases; Mice; Mice, Inbred BALB C; Mice, Nude; RNA; RNA Processing, Post-Transcriptional; RNA-Binding Proteins; Snail Family Transcription Factors; Tissue Array Analysis; Up-Regulation; Xenograft Model Antitumor Assays | 2019 |
LncRNA MEG3 contributes to adenosine-induced cytotoxicity in hepatoma HepG2 cells by downregulated ILF3 and autophagy inhibition via regulation PI3K-AKT-mTOR and beclin-1 signaling pathway.
Topics: Adenosine; Apoptosis; Autophagy; Beclin-1; Carcinoma, Hepatocellular; Cell Survival; Down-Regulation; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Nuclear Factor 90 Proteins; Phosphatidylinositol 3-Kinases; Phosphotransferases; Proto-Oncogene Proteins c-akt; RNA, Long Noncoding; Signal Transduction; TOR Serine-Threonine Kinases | 2019 |
Preclinical evaluation of transcriptional targeting strategy for human hepatocellular carcinoma in an orthotopic xenograft mouse model.
Topics: Adenosine; Animals; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Disease Models, Animal; Female; Gene Expression; Genetic Therapy; Genetic Vectors; Humans; Liver Neoplasms; Mice; Regulatory Sequences, Nucleic Acid; Transcription, Genetic; Transgenes; Xenograft Model Antitumor Assays | 2013 |
A novel role of the tumor suppressor GNMT in cellular defense against DNA damage.
Topics: Adenosine; Animals; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cell Nucleus; Cells, Cultured; Chromatography, High Pressure Liquid; Dietary Supplements; DNA Damage; DNA Methylation; Female; Fluorescent Antibody Technique, Indirect; Folic Acid; Glycine N-Methyltransferase; Hepatocytes; Homocysteine; Humans; Liver; Liver Neoplasms; Male; Methylenetetrahydrofolate Dehydrogenase (NADP); Mice; Mice, Knockout; Minor Histocompatibility Antigens; Protein Transport; Purines; Pyrimidines; S-Adenosylhomocysteine; S-Adenosylmethionine; Tetrahydrofolates; Uracil | 2014 |
Enhanced antitumor effects of adenoviral-mediated siRNA against GRP78 gene on adenosine-induced apoptosis in human hepatoma HepG2 cells.
Topics: Adenosine; Adenoviridae; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Hepatocellular; Caspases, Initiator; Down-Regulation; Endoplasmic Reticulum Chaperone BiP; G1 Phase Cell Cycle Checkpoints; Genetic Vectors; Heat-Shock Proteins; Hep G2 Cells; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; RNA Interference; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Transcription Factor CHOP | 2014 |
Adenosine induces apoptosis in human liver cancer cells through ROS production and mitochondrial dysfunction.
Topics: Adenosine; Apoptosis; Caspases; Cell Line, Tumor; Cell Survival; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Reactive Oxygen Species | 2014 |
The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer.
Topics: Adenosine; Animals; Antineoplastic Agents; Bone Neoplasms; Drug Screening Assays, Antitumor; Female; Gene Expression; Liver Neoplasms; Lung Neoplasms; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Transplantation; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Ticagrelor | 2015 |
The mechanism of adenosine-mediated activation of lncRNA MEG3 and its antitumor effects in human hepatoma cells.
Topics: Adenosine; Apoptosis; Azacitidine; Carcinoma, Hepatocellular; Cell Proliferation; CpG Islands; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Neoplasm Proteins; Promoter Regions, Genetic; RNA, Long Noncoding | 2016 |
METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N
Topics: Adenosine; Animals; Carcinoma, Hepatocellular; Disease Models, Animal; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Methyltransferases; Mice; Mice, Inbred BALB C; MicroRNAs; Neoplasm Metastasis; RNA Interference; Sensitivity and Specificity; Signal Transduction; Survival Rate; Tumor Cells, Cultured | 2017 |
MicroRNA-145 Modulates
Topics: 3' Untranslated Regions; Adenosine; Carcinoma, Hepatocellular; Cell Proliferation; Down-Regulation; Hep G2 Cells; Humans; Immunohistochemistry; Liver Neoplasms; MicroRNAs; Microscopy, Fluorescence; Mutation; Plasmids; Protein Binding; Protein Domains; RNA-Binding Proteins; RNA, Small Interfering | 2017 |
Comparison of University of Wisconsin and ET-Kyoto preservation solutions for the cryopreservation of primary human hepatocytes.
Topics: Adenosine; Adult; Aged; Allopurinol; Cell Culture Techniques; Cell Survival; Female; Gluconates; Glutathione; Hepatectomy; Hepatocytes; Humans; Hydroxyethyl Starch Derivatives; Insulin; Liver Neoplasms; Male; Middle Aged; Organ Preservation Solutions; Phosphates; Raffinose; Tissue Preservation; Trehalose | 2008 |
The A3 adenosine receptor agonist CF102 induces apoptosis of hepatocellular carcinoma via de-regulation of the Wnt and NF-kappaB signal transduction pathways.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Adult; Aged; Aged, 80 and over; Animals; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Liver Neoplasms; Male; Middle Aged; NF-kappa B; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A3; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Wnt Proteins | 2008 |
Greater hemodynamic instability with histidine-tryptophan-ketoglutarate solution than University of Wisconsin solution during the reperfusion period in living donor liver transplantation.
Topics: Acid-Base Equilibrium; Adenosine; Adult; Allopurinol; Blood Pressure; Carcinoma, Hepatocellular; Female; Glucose; Glutathione; Hemodynamics; Humans; Insulin; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Living Donors; Male; Mannitol; Middle Aged; Organ Preservation Solutions; Portal Vein; Potassium; Potassium Chloride; Procaine; Raffinose; Reperfusion Injury; Retrospective Studies | 2008 |
Tuning of apoptosis-mediator gene transcription in HepG2 human hepatoma cells through an adenosine signal.
Topics: Adenosine; Apoptosis; Carcinoma, Hepatocellular; Caspase 9; Caspases; Cell Cycle; Cell Line, Tumor; Cell Survival; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Liver Neoplasms; Receptors, Tumor Necrosis Factor; RNA, Messenger; RNA, Neoplasm; Transcription, Genetic; Up-Regulation | 2010 |
Adenosine-induced caspase-3 activation by tuning Bcl-XL/DIABLO/IAP expression in HuH-7 human hepatoma cells.
Topics: Adenosine; Apoptosis Regulatory Proteins; Baculoviral IAP Repeat-Containing 3 Protein; bcl-X Protein; Biological Transport; Blotting, Western; Carcinoma, Hepatocellular; Caspase 3; Caspase 9; Cell Line, Tumor; Down-Regulation; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Intracellular Signaling Peptides and Proteins; Intracellular Space; Liver Neoplasms; Membrane Potential, Mitochondrial; Mitochondrial Proteins; Protease Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Ubiquitin-Protein Ligases; Up-Regulation | 2010 |
Involvement of NF-kappaB activation in the apoptosis induced by extracellular adenosine in human hepatocellular carcinoma HepG2 cells.
Topics: Adenosine; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Hepatocellular; Caspase 3; Cell Cycle; Cell Survival; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Extracellular Space; Hep G2 Cells; Humans; Liver Neoplasms; NF-kappa B; Proline; Thiocarbamates | 2010 |
Involvement of endoplasmic reticulum stress in adenosine-induced human hepatoma HepG2 cell apoptosis.
Topics: Adenosine; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Caspases, Initiator; Cell Proliferation; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Gene Expression Regulation, Neoplastic; Heat-Shock Proteins; Hep G2 Cells; Humans; Liver Neoplasms; Tetrazolium Salts; Thiazoles; Transcription Factor CHOP | 2011 |
CF102 an A3 adenosine receptor agonist mediates anti-tumor and anti-inflammatory effects in the liver.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Concanavalin A; Hepatitis; Liver; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Receptor, Adenosine A3; Signal Transduction; Xenograft Model Antitumor Assays | 2011 |
3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cells.
Topics: Adenosine; Adenosylhomocysteinase; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA Methylation; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Histones; Humans; Liver Neoplasms; Mice; Neoplastic Stem Cells; Polycomb Repressive Complex 2; Transcription Factors | 2012 |
Identification of serum biomarkers of hepatocarcinoma through liquid chromatography/mass spectrometry-based metabonomic method.
Topics: Adenosine; Adult; alpha-Fetoproteins; Biomarkers, Tumor; Carcinoma, Hepatocellular; Chromatography, Liquid; Humans; Liver Neoplasms; Mass Spectrometry; Metabolomics; Middle Aged | 2011 |
Synthesis of novel 6-(4-substituted piperazine-1-yl)-9-(β-D-ribofuranosyl)purine derivatives, which lead to senescence-induced cell death in liver cancer cells.
Topics: Adenosine; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Death; Cell Line, Tumor; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p15; Drug Screening Assays, Antitumor; Humans; Liver Neoplasms; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Purine Nucleosides; Retinoblastoma Protein; Structure-Activity Relationship | 2012 |
Radiofrequency ablation: effect of tumor- and organ-specific pharmacologic modulation of arterial and portal venous blood flow on coagulation diameter in an N1-S1 tumor model.
Topics: Adenosine; Animals; Blood Flow Velocity; Carcinoma, Hepatocellular; Catheter Ablation; Cell Line, Tumor; Contrast Media; Glucagon; Hepatic Artery; Injections, Intravenous; Liver Circulation; Liver Neoplasms; Microcirculation; Necrosis; Perfusion Imaging; Portal Vein; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Time Factors; Tumor Burden; Ultrasonography; Vasodilator Agents | 2012 |
[STUDY OF THE ENZYMES OF ADENOSINE CATABOLISM IN THE RAT LIVER DURING THE GROWTH PROCESS].
Topics: Adenosine; Aminohydrolases; Growth; Hepatectomy; Hypertrophy; Liver; Liver Neoplasms; Nucleosides; Phosphotransferases; Rats; Research; Transferases; Xanthine Oxidase | 1964 |
Inhibition of primary colon carcinoma growth and liver metastasis by the A3 adenosine receptor agonist CF101.
Topics: Adenosine; Administration, Oral; Animals; Biological Availability; Carcinoma; Cell Division; Colonic Neoplasms; Disease Models, Animal; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Purinergic P1 Receptor Agonists; Transplantation, Heterologous; Tumor Cells, Cultured | 2003 |
ATP-sensitive K(+) channels regulate the concentrative adenosine transporter CNT2 following activation by A(1) adenosine receptors.
Topics: Adenosine; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Membrane; Glucose; Hepatocytes; Liver Neoplasms; Male; Membrane Transport Proteins; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Protein Isoforms; Protein Subunits; Purine Nucleosides; Rats; Rats, Wistar; Receptor, Adenosine A1 | 2004 |
Molecular mechanisms of adenosine-induced apoptosis in human HepG2 cells.
Topics: Adenosine; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dipyridamole; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Liver Neoplasms; Membrane Potentials; Mitochondria, Liver; Theophylline | 2006 |
Intracellularly transported adenosine induces apoptosis in HuH-7 human hepatoma cells by downregulating c-FLIP expression causing caspase-3/-8 activation.
Topics: Adenosine; Apoptosis; Biological Transport; Carcinoma, Hepatocellular; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 3; Caspase 8; Down-Regulation; Enzyme Activation; Gene Expression; Humans; Liver Neoplasms; Tumor Cells, Cultured | 2007 |
Adenosine metabolism and its effect on methylation potential in cultured cells: methodological considerations.
Topics: Adenine Nucleotides; Adenosine; Carcinoma, Hepatocellular; Cell Culture Techniques; Cell Line, Tumor; Chelating Agents; Culture Media; Edetic Acid; Humans; Inosine; Kinetics; Liver Neoplasms; Methylation; S-Adenosylmethionine; Time Factors; Trypsin | 2007 |
Sp1 is involved in 8-chloro-adenosine-upregulated death receptor 5 expression in human hepatoma cells.
Topics: Adenosine; Antineoplastic Agents; Base Sequence; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Electrophoretic Mobility Shift Assay; Humans; Immunoglobulins; Immunoprecipitation; Liver Neoplasms; Molecular Sequence Data; Promoter Regions, Genetic; Protein Biosynthesis; Receptors, TNF-Related Apoptosis-Inducing Ligand; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic; Up-Regulation | 2008 |
Neoplastic conversion of rat liver epithelial cells in culture by ethionine and S-adenosylethionine.
Topics: Adenosine; Animals; Carcinogens; Cell Transformation, Neoplastic; Cells, Cultured; Ethionine; Liver; Liver Neoplasms; Neoplasms, Experimental; Rats; Rats, Inbred F344 | 1983 |
Enhancement of erythropoietin production by selective adenosine A2 receptor agonists in response to hypoxia.
Topics: Adenosine; Animals; Binding, Competitive; Carcinoma, Hepatocellular; Cyclic AMP; Erythropoietin; Female; Humans; Hypoxia; Kinetics; Liver Neoplasms; Mice; Phenethylamines; Polycythemia; Purinergic P1 Receptor Agonists; Tumor Cells, Cultured | 1995 |
In situ and ex situ in vivo procedures for complex major liver resections requiring prolonged hepatic vascular exclusion in normal and diseased livers.
Topics: Adenosine; Allopurinol; Blood Loss, Surgical; Constriction; Embolism, Air; Follow-Up Studies; Glutathione; Hepatectomy; Hepatic Veins; Humans; Hypothermia, Induced; Insulin; Ischemia; Ligation; Liver Circulation; Liver Diseases; Liver Failure; Liver Neoplasms; Organ Preservation Solutions; Perfusion; Portal Vein; Raffinose; Survival Rate; Time Factors; Tissue Preservation; Vena Cava, Inferior | 1995 |
Adenosine A1 receptors and erythropoietin production.
Topics: Adenosine; Carcinoma, Hepatocellular; Colforsin; Cyclic AMP; Erythropoietin; Humans; Liver Neoplasms; Receptors, Purinergic P1; Tumor Cells, Cultured | 1993 |
Effects of 5'-N-ethylcarboxamideadenosine (NECA) on erythropoietin production.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Erythropoietin; Female; Hypoxia; Liver Neoplasms; Mice; Mice, Inbred Strains; Osmolar Concentration; Polycythemia; Theophylline; Tumor Cells, Cultured | 1993 |
[Increase in erythropoietin secretion mediated by adenosine A2 receptors].
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Carcinoma, Hepatocellular; Cell Hypoxia; Cyclic AMP; Erythropoietin; Humans; Liver Neoplasms; Receptors, Purinergic; Theophylline; Tumor Cells, Cultured | 1993 |
Prevention of human pancreatic cancer cell-induced hepatic metastasis in nude mice by dipyridamole and its analog RA-233.
Topics: Adenosine; Animals; Dipyridamole; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Liver Neoplasms; Mice; Mice, Nude; Mopidamol; Pancreatic Neoplasms; Platelet Aggregation; Tumor Cells, Cultured | 1993 |
Suppression by phenobarbital of ethionine-induced hepatocellular carcinoma formation and hepatic S-adenosylethionine levels.
Topics: Adenosine; Animals; Body Weight; Ethionine; Liver; Liver Neoplasms; Male; Methylation; Organ Size; Phenobarbital; Rats; Rats, Inbred F344; S-Adenosylmethionine | 1997 |
Adenosine A(2A) and A(2B) receptor activation of erythropoietin production.
Topics: Adenosine; Alkaloids; Benzophenanthridines; Carcinoma, Hepatocellular; Enzyme Activation; Erythropoietin; Humans; Liver Neoplasms; Phenanthridines; Phenethylamines; Protein Kinase C; Purinergic P1 Receptor Antagonists; Pyrimidines; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Receptors, Purinergic P1; RNA, Messenger; Triazoles; Tumor Cells, Cultured; Xanthines | 2001 |
Vinyl chloride and trichloroethylene: comparison of alkylating effects of metabolites and induction of preneoplastic enzyme deficiencies in rat liver.
Topics: Adenosine; Adenosine Triphosphatases; Alkylation; Animals; Animals, Newborn; Chromatography, Ion Exchange; Cytidine; Female; Liver; Liver Neoplasms; Mitochondria, Liver; Rats; RNA; Trichloroethylene; Vinyl Chloride; Vinyl Compounds | 1979 |
Inhibition of de novo pyrimidine nucleotide and DNA synthesis and growth of cultured Novikoff rat hepatoma cells and other cell lines by pyrazofurin (NSC 143095).
Topics: Adenosine; Amides; Anti-Bacterial Agents; Carcinoma, Hepatocellular; Cell Division; Cells, Cultured; Deoxycytidine Monophosphate; Dipyridamole; DNA; DNA, Neoplasm; HeLa Cells; L Cells; Liver Neoplasms; Neoplasms, Experimental; Pyrazoles; Pyrimidine Nucleotides; Ribonucleosides; Ribose; RNA; Thymidine; Uridine | 1976 |
Incorporation of adenosine into ATP: formation of compartmentalized ATP.
Topics: Adenine; Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Hypoxanthines; Liver; Liver Neoplasms; Mice; Mice, Nude; Neoplasms, Experimental | 1976 |
Growth rate of cultured Novikoff rat hepatoma cells as a function of the rate of thymidine and hypoxanthine transport.
Topics: Adenosine; Animals; Biological Transport; Carcinoma, Hepatocellular; Cell Survival; Cells, Cultured; Dipyridamole; Guanosine; Hypoxanthines; Liver Neoplasms; Methotrexate; Neoplasms, Experimental; Rats; Thymidine; Thymine Nucleotides | 1977 |
Characterization of N6, O2-dimethyladenosine from nuclear RNA of Novikoff hepatoma.
Topics: Adenosine; Carcinoma, Hepatocellular; Cell Line; Cell Nucleus; Liver Neoplasms; Mass Spectrometry; Neoplasms, Experimental; RNA, Neoplasm | 1978 |
Adenosine deaminase and adenosine kinase in rat hepatomas and kidney tumours.
Topics: Adenosine; Adenosine Deaminase; Adenosine Kinase; Animals; Carcinoma, Hepatocellular; Cell Differentiation; Cells, Cultured; Kidney Neoplasms; Kinetics; Liver; Liver Neoplasms; Liver Regeneration; Male; Neoplasms, Experimental; Nucleoside Deaminases; Phosphotransferases; Rats; Tissue Distribution | 1978 |
N6(Methylnitroso)adenosine: a carcinogenic nitrosamine derived from a naturally-occurring nucleoside.
Topics: Adenosine; Animals; Carcinogens; Female; Liver Neoplasms; Lung Neoplasms; Lymphoma; Male; Maternal-Fetal Exchange; Mice; Neoplasms, Experimental; Nitrosamines; Pregnancy | 1979 |
The influence of DL-methionine on the metabolism of S-adenosylethionine in rats chronically treated with DL-ethionine.
Topics: Adenosine; Adenosine Triphosphate; Animals; Body Weight; Circadian Rhythm; Ethionine; Feeding Behavior; Female; Liver; Liver Neoplasms; Methionine; Neoplasms, Experimental; Rats; S-Adenosylhomocysteine; S-Adenosylmethionine | 1976 |
Mechanism of suppressive effect of basic cupric acetate on rat liver carcinogenesis by ethionine.
Topics: Adenosine; Alkylation; Animals; Copper; Drug Interactions; Ethionine; Liver; Liver Neoplasms; Male; Methionine; Microsomes, Liver; Neoplasms, Experimental; Rats; RNA, Transfer | 1976 |
Increased erythropoietin secretion in human hepatoma cells by N6-cyclohexyladenosine.
Topics: Adenosine; Anaerobiosis; Bucladesine; Carcinoma, Hepatocellular; Cell Line; Cell Survival; Cyclic AMP; Erythropoietin; Humans; Hypoxia; Kinetics; Liver Neoplasms; Theophylline | 1991 |
Multiple abdominal visceral transplantation: clinical experience of organ preservation by University of Wisconsin (UW) solution.
Topics: Adenoma, Bile Duct; Adenosine; Adult; Allopurinol; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Colonic Neoplasms; Duodenal Neoplasms; Duodenum; Female; Glutathione; Humans; Insulin; Intestine, Small; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Organ Preservation; Organ Preservation Solutions; Pancreas Transplantation; Pancreatic Neoplasms; Raffinose; Solutions | 1991 |
Further evidence against post-transcriptional control of inducible tyrosine aminotransferase synthesis in cultured hepatoma cells.
Topics: Adenosine; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cells, Cultured; Dactinomycin; Deoxyadenosines; Enzyme Induction; Enzyme Repression; Hydrocortisone; Kinetics; Leucine; Liver Neoplasms; RNA, Messenger; RNA, Ribosomal; Transcription, Genetic; Tritium; Tyrosine Transaminase | 1973 |
Nucleoside transport by Novikoff rat hepatoma cells glowing in suspension culture. Specificity and mechanism of transport reactions and relationship to nucleoside incorporation into nucleic acids.
Topics: Adenosine; Biological Transport; Carcinoma, Hepatocellular; Cell Line; Cells, Cultured; Chloromercuribenzoates; Chromatography, Paper; Chymotrypsin; Cytidine; Dipyridamole; Ethanol; Guanosine; Hot Temperature; Inosine; Kinetics; Liver Neoplasms; Neoplasms, Experimental; Neuraminidase; Nucleic Acids; Nucleosides; Phospholipases; Phosphotransferases; Thymidine; Tritium; Trypsin; Uridine | 1971 |
Growth of Novikoff rat hepatoma cells in suspension culture in the presence of adenosine 3',5'-cyclic monophosphate.
Topics: Adenine Nucleotides; Adenosine; Carcinoma, Hepatocellular; Chromatography, Paper; Culture Techniques; Cyclic AMP; HeLa Cells; L Cells; Liver Neoplasms; Mitosis; Neoplasms, Experimental; Phosphoric Monoester Hydrolases; Stimulation, Chemical; Tritium | 1971 |
Effects of 3'deoxyadenosine (cordycepin) and 2'deoxyadenosine on nucleoside transport, macromolecular synthesis, and replication of cultured Novikoff hepatoma cells.
Topics: Adenosine; Adenosine Triphosphate; Amino Acids; Animals; Biological Transport; Carcinoma, Hepatocellular; Cell Division; Cell Line; Centrifugation, Density Gradient; Chromatography, Paper; Culture Techniques; Cytosine Nucleotides; Deoxyadenosines; DNA, Neoplasm; Electrophoresis, Paper; Kinetics; Liver Neoplasms; Metabolism; Neoplasm Proteins; Neoplasms, Experimental; Nucleoside Diphosphate Sugars; Nucleosides; Nucleotides; Rats; RNA, Neoplasm; RNA, Transfer; Thymidine; Tritium; Uracil Nucleotides; Uridine | 1971 |
Nucleotide pools in Novikoff rat hepatoma cells growing in suspension culture. 3. Effects of nucleosides in medium on levels of nucleotides in separate nucleotide pools for nuclear and cytoplasmic RNA synthesis.
Topics: Adenine Nucleotides; Adenosine; Animals; Carbon Isotopes; Carcinoma, Hepatocellular; Cell Line; Cell Nucleus; Cells, Cultured; Chromatography; Culture Media; Culture Techniques; Cytidine; Cytoplasm; Cytosine Nucleotides; Electrophoresis; Encephalomyocarditis virus; Guanosine; Inosine; Liver Neoplasms; Neoplasms, Experimental; Nucleosides; Nucleotides; Phosphates; Phosphorus Isotopes; Rats; RNA; RNA, Viral; Time Factors; Tritium; Uridine | 1972 |
Competing methyltransferase systems.
Topics: Adenosine; Animals; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Cell Nucleus; Cytoplasm; Glycine; Homocysteine; Kidney; Liver; Liver Neoplasms; Methylation; Methyltransferases; Mice; Molecular Weight; Pancreas; Rabbits; Rats; RNA, Bacterial; RNA, Transfer; S-Adenosylmethionine | 1972 |
Purification of mengovirus and identification of an A-rich segment in its ribonucleic acid.
Topics: Adenosine; Adenosine Monophosphate; Animals; Carbon Isotopes; Carcinoma, Hepatocellular; Cell Line; Centrifugation, Density Gradient; Liver Neoplasms; Mengovirus; Methods; Molecular Weight; Polynucleotides; Rats; Ribonucleases; RNA, Viral; Tritium; Ultrafiltration; Uridine | 1972 |
Transport and metabolism of glucosamine by cultured Novikoff rat hepatoma cells and effects on nucleotide pools.
Topics: Adenine Nucleotides; Adenosine; Animals; Biological Transport; Carbon Dioxide; Carbon Isotopes; Carcinoma, Hepatocellular; Cells, Cultured; Chromatography, Paper; Cycloheximide; Cytochalasin B; Diffusion; Dipyridamole; Glucosamine; Glucose; Lactates; Liver Neoplasms; Neoplasms, Experimental; Puromycin; Rats; Ribonucleotides; Tritium; Uracil Nucleotides; Uridine; Uridine Diphosphate Sugars | 1973 |
Guanosine anabolism for biosynthesis of nucleic acids in Novikoff ascites rat tumor cells in culture.
Topics: Adenosine; Animals; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cells, Cultured; Chromatography, DEAE-Cellulose; DNA, Neoplasm; Electrophoresis, Paper; Guanosine; Liver Neoplasms; Neoplasms, Experimental; Nucleotidyltransferases; Phosphotransferases; Rats; RNA, Neoplasm | 1973 |
Nuclear ribonucleoprotein complexes containing polyadenylate from mouse ascites cells.
Topics: Adenine Nucleotides; Adenosine; Animals; Ascitic Fluid; Carcinoma, Hepatocellular; Cell Line; Centrifugation, Density Gradient; Electrophoresis, Polyacrylamide Gel; Liver Neoplasms; Mice; Micropore Filters; Neoplasms, Experimental; Nucleoproteins; Peptides; Polynucleotides; RNA; Tritium | 1974 |
Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells.
Topics: Adenosine; Carcinoma, Hepatocellular; Cell Fractionation; Cell Line; Cellulose; Chromatography; Cytidine; Guanosine; Liver Neoplasms; Methylation; Neoplasms, Experimental; Nucleosides; Oligonucleotides; Polyribosomes; RNA, Messenger; RNA, Neoplasm; Thymine Nucleotides | 1974 |
Automated method for determination of serum 5'-nucleotidase activity.
Topics: Adenosine; Alkaline Phosphatase; Aminohydrolases; Autoanalysis; Bone Diseases; Clinical Enzyme Tests; Colorimetry; Creatine Kinase; Evaluation Studies as Topic; Humans; Liver Diseases; Liver Neoplasms; Magnesium; Methods; Neoplasm Metastasis; Nickel; Nucleotidases | 1972 |
[Serum adenosine desaminase in liver diseases].
Topics: Adenosine; Aminohydrolases; Cholangitis; Cholecystitis; Cholelithiasis; Cholestasis; Chronic Disease; Clinical Enzyme Tests; Fatty Liver; Hepatitis; Hepatitis A; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Diseases; Liver Neoplasms | 1973 |